1. In Vivo

The Biotech Balancing Act: Long-Term Vision Vs. Inflection Points

 
• By David Wild

Tuyen Ong, a CEO-partner at Flagship Pioneering and CEO of Ring Therapeutics, discusses the importance of balancing short-term wins with a longer-term vision when building a biotech.   

Business Balance - A businessman carrying paperwork walking over a tight rope.

Rising Leaders Home

One of In Vivo’s 2024 Rising Leaders, Tuyen Ong is familiar with scaling biotech companies. He was previously chief development...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Rising Leaders

More from Leadership